BioVendor – Laboratorni Medicina as:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:BioVendor - Laboratorni Medicina as - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10891
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:チェコ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioVendor – Laboratorni Medicina as (BioVendor) is a developer and manufacturer of immunoassays, recombinant protiens, antibodies and endotoxin-removal products. The company provides products such as immunoassays, proteins, antibodies, endotoxin removal products, endotoxin detection products, immuno-histochemistry, cell-based assays and colorimetric assays, among others. Its products are used in animal studies, apoptosis, asthma and allergic rhinitis, atherosclerosis, autoimmunity, blood pressure regulation and no metabolism, bone and cartilage metabolism, cardiovascular disease, cell adhesion proteins and research applications, among others. BioVendor markets its products through a network of distributors in Andorra, Belgium, Cyprus, Denmark, Finland, France, Greece, Greenland, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, the Netherlands, Norway, Portugal, Spain, Sweden, the Czech Republic and the UK, among others. BioVendor is headquartered in Brno, the Czech Republic.

BioVendor – Laboratorni Medicina as – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioVendor – Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioVendor – Laboratorni Medicina as, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioVendor – Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioVendor – Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BioVendor – Laboratorni Medicina as, Medical Devices Deals, 2012 to YTD 2018 9
BioVendor – Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BioVendor – Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
AIT Austrian Institute Enters into Co-Development Agreement with BioVendor and Scienion 11
Licensing Agreements 12
BioVendor Enters into Licensing Agreement with Atlantic Cancer Research Institute 12
Acquisition 13
Anteo Diagnostics Sells DIAsource to BioVendor for USD19 Million 13
Anteo Diagnostics Completes Acquisition of DIAsource for USD16.7 Million 14
BioVendor – Laboratorni Medicina as – Key Competitors 15
BioVendor – Laboratorni Medicina as – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
BioVendor - Laboratorni Medicina as, Pharmaceuticals & Healthcare, Key Facts 2
BioVendor - Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioVendor - Laboratorni Medicina as, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioVendor - Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioVendor - Laboratorni Medicina as, Deals By Therapy Area, 2012 to YTD 2018 8
BioVendor - Laboratorni Medicina as, Medical Devices Deals, 2012 to YTD 2018 9
BioVendor - Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
AIT Austrian Institute Enters into Co-Development Agreement with BioVendor and Scienion 11
BioVendor Enters into Licensing Agreement with Atlantic Cancer Research Institute 12
Anteo Diagnostics Sells DIAsource to BioVendor for USD19 Million 13
Anteo Diagnostics Completes Acquisition of DIAsource for USD16.7 Million 14
BioVendor - Laboratorni Medicina as, Key Competitors 15
BioVendor - Laboratorni Medicina as, Subsidiaries 16

List of Figures
BioVendor - Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
BioVendor - Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
BioVendor - Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
BioVendor - Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
BioVendor - Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioVendor - Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
BioVendor - Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioVendor - Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BioVendor - Laboratorni Medicina as, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[BioVendor – Laboratorni Medicina as:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bankinter, S.A.:企業のM&A・事業提携・投資動向
    Bankinter, S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bankinter, S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Energy Absolute Public Co Ltd (EA):電力:M&Aディール及び事業提携情報
    Summary Energy Absolute Public Co Ltd (Energy Absolute), formerly Suntech Palm Oil Ltd, is a renewable energy service provider that offers opportunities for networking, education and business creation. The company provides products such as biodiesel and glycerin. It offers services such as dry washi …
  • SpineGuard, S.A. (ALSGD):企業財務及び戦略的SWOT分析
    Summary SpineGuard, S.A. (SpineGuard) is a medical device company that designs, develops and markets spine surgery products. The company offers PediGuard, a device that detects possible vertebral cortex perforation during pedicle preparation for screw placement and alerts the surgeon prior to a brea …
  • Acerinox, S.A. (ACX):企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Acerinox, S.A." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly follows a …
  • Viscofan, S.A.:企業概要・SWOT・財務分析
    Summary Canadean's "Viscofan, S.A. : Consumer Packaged Goods - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business descripti …
  • Knight Square Holdings Ltd:企業の戦略・SWOT・財務情報
    Knight Square Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Knight Square Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Ergon Energy:企業の戦略・SWOT・財務分析
    SummaryErgon Energy - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - …
  • OGK-2 (OGKB):企業のM&A・提携動向(エネルギー分野)
    Summary OGK-2, a subsidiary of Gazprom Energoholding, is an energy company that carries out generation and supply of electricity and heat through its multiple power plants located in Russian Federation. Its power plants consist of TPP, Kirishskaya GRES, Pskovskaya GRES, Novocherkasskskaya GRES, Ryaz …
  • Positron Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Positron Corporation Mergers an …
  • Yildiz Holding A.S.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Yildiz Holding A.S. Mergers and …
  • Optus Inc:企業の戦略的SWOT分析
    Optus Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Industrial Securities Co. Ltd.の企業概要及び財務/SWOT分析
    Industrial Securities Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Industrial Securities Co. Ltd. annual and quarterly forecasts made by stock market experts. The …
  • TKH Group NV (TWEKA):企業財務及び戦略的SWOT分析
    Summary TKH Group NV (TKH) is a technology company that develops and delivers systems and networks. The company’s solutions include telecom solutions, building solutions and industrial solutions. It provides telecom solutions such as fibre network systems, copper network systems, and indoor telecom …
  • HIMACS, Ltd. (4299):企業の財務及び戦略的SWOT分析
    Summary HIMACS, Ltd. (HIMACS) is a technology company that offers software solutions. The company’s services include system solution services and system maintenance services. It provides process for various system lifecycles, planning of computer software system, design and development phase, and ma …
  • Keyang Electric Machinery Co., Ltd.の企業概要及び財務/SWOT分析
    Keyang Electric Machinery Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual …
  • Ezra Holdings Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Ezra Holdings Limited Mergers a …
  • Green Plains Inc.:企業のM&A・事業提携・投資動向
    Green Plains Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Green Plains Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Clyde Blowers Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Clyde Blowers Ltd. Mergers and …
  • ethris GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Ethris GmbH (Ethris) is a biotech company that develops RNA-based therapies. The company develops therapeutics based on its proprietary platform technologies. It uses technologies including magnetovax and SNIM RNA. Ethris’ magnetovax is a platform for personalized tumor vaccines localized an …
  • Kyocera Corporation (6971):電力:M&Aディール及び事業提携情報
    Summary Kyocera Corporation (Kyocera) is a provider of electronic equipment and components. The company’s portfolio includes semiconductor parts, ceramic components, mobile phones, electronic devices, telecommunications and information equipment, and others. These products find application in variou …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆